Chemical Compound
(5alpha)-(5'alpha)-4,5:4',5'-diepoxy-3,3',14,14'-tetrahydroxy-17,17'-bis(2-propen-1-yl)-[2,2'-bimorphinan]-6,6'-dione; [2,2'-Bimorphinan]-6,6'-dione, 4,5:4',5'-diepoxy-3,3',14,14'-tetrahydroxy-17,17'-bis(2-propenyl)-, (5alpha)-(5'alpha)- (9CI); 2,2'-Bisnaloxone; Naloxone Hydrochloride Dihydrate Imp. E (EP)
CAS Registry Number
211738-08-8
Primary record
(5alpha)-(5'alpha)-4,5:4',5'-diepoxy-3,3',14,14'-tetrahydroxy-17,17'-bis(2-propen-1-yl)-[2,2'-bimorphinan]-6,6'-dione; [2,2'-Bimorphinan]-6,6'-dione, 4,5:4',5'-diepoxy-3,3',14,14'-tetrahydroxy-17,17'-bis(2-propenyl)-, (5alpha)-(5'alpha)- (9CI); 2,2'-Bisnaloxone; Naloxone Hydrochloride Dihydrate Imp. E (EP)
- 库存
- 5,486 克
- 纯度
- 99.4 %
- CAS
- 211738-08-8
化合物标识与属性
- CAS
- 211738-08-8
- PubChem CID
- 129011921
- SMILES
- C=CCN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=CC(=C(C(=C35)O4)O)C6=C(C7=C8C(=C6)C[C@@H]9[C@]1([C@]8(CCN9CC=C)[C@@H](O7)C(=O)CC1)O)O)O
- Canonical SMILES
- C=CCN1CC[C@]23c4c5cc(-c6cc7c8c(c6O)O[C@H]6C(=O)CC[C@@]9(O)[C@@H](C7)N(CC=C)CC[C@]869)c(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5
名称与同义词
- 2,2'-Bisnaloxone
- Naloxone EP Impurity E
- RefChem:196413
- L22Y8K98TP
- UNII-L22Y8K98TP
- SCHEMBL29462965
- 211738-08-8
- Naloxone Hydrochloride EP Impurity E
- CS-O-11940
- PD198072
- Naloxone hydrochloride dihydrate impurity E
- 2,2'-Bisnaloxone (1mg/ml in Acetonitrile)
- Naloxone hydrochloride dihydrate impurity E [EP]
- 2,2'-Bisnaloxone (1 mg/ml in Acetonitrile)
- NALOXONE HYDROCHLORIDE DIHYDRATE IMPURITY E [EP IMPURITY]
- (4R,4aS,7aR,12bS)-10-[(4R,4aS,7aR,12bS)-4a,9-dihydroxy-7-oxo-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-10-yl]-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one
- NALOXONE HYDROCHLORIDE DIHYDRATE IMPURITY E (EP IMPURITY)
- (2,2'-BIMORPHINAN)-6,6'-DIONE, 4,5:4',5'-DIEPOXY-3,3',14,14'-TETRAHYDROXY-17,17'-BIS(2-PROPEN-1-YL)-, (5.ALPHA.)-(5'.ALPHA.)-
- (2,2'-Bimorphinan)-6,6'-dione, 4,5:4',5'-diepoxy-3,3',14,14'-tetrahydroxy-17,17'-bis(2-propen-1-yl)-, (5alpha)-(5'alpha)-
- (4R,4'R,5S,5'S,9R,9'R,17S,17'S)-3,3'-diallyl-5,5',12,12'-tetrahydroxy-2,2',3,3',4,4',5,5',6,6',7,7',9,9',18,18'-hexadecahydro-[13,13'-bi(4,12-methanobenzofuro[3,2-e]isoquinoline)]-8,8'(1H,1'H)-dione
- (5.ALPHA.)-(5'.ALPHA.)-4,5:4',5'-DIEPOXY-3,3',14,14'-TETRAHYDROXY-17,17'-BIS(2-PROPEN-1-YL)(2,2'-BIMORPHINAN)-6,6'-DIONE
- (5alpha)-(5'alpha)-4,5:4',5'-Diepoxy-3,3',14,14'-tetrahydroxy-17,17'-bis(2-propen-1-yl)(2,2'-bimorphinan)-6,6'-dione
- (5alpha)-(5'alpha)-4,5:4',5'-diepoxy-3,3',14,14'-tetrahydroxy-17,17'-bis(2-propen-1-yl)-[2,2'-bimorphinan]-6,6'-dione; [2,2'-Bimorphinan]-6,6'-dione, 4,5:4',5'-diepoxy-3,3',14,14'-tetrahydroxy-17,17'-bis(2-propenyl)-, (5alpha)-(5'alpha)- (9CI); 2,2'-Bisnaloxone; Naloxone Hydrochloride Dihydrate Imp. E (EP)
- [2,2'-Bimorphinan]-6,6'-dione, 4,5:4',5'-diepoxy-3,3',14,14'-tetrahydroxy-17,17'-bis(2-propen-1-yl)-, (5|A)-(5'|A)-
- 4,5.ALPHA.:4,5.ALPHA.-DIEPOXY-3,3,14,14-TETRAHYDROXY-17,17-BIS(PROP-2-ENYL)-2,2-BIMORPHINANYL-6,6-DIONE
- 4,5alpha:4,5alpha-Diepoxy-3,3,14,14-tetrahydroxy-17,17-bis(prop-2-enyl)-2,2-bimorphinanyl-6,6-dione